144 related articles for article (PubMed ID: 7635257)
21. Pharmacological evaluation and docking studies of α,β-unsaturated carbonyl based synthetic compounds as inhibitors of secretory phospholipase A₂, cyclooxygenases, lipoxygenase and proinflammatory cytokines.
Bukhari SN; Lauro G; Jantan I; Bifulco G; Amjad MW
Bioorg Med Chem; 2014 Aug; 22(15):4151-61. PubMed ID: 24938495
[TBL] [Abstract][Full Text] [Related]
22. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition.
Geronikaki AA; Lagunin AA; Hadjipavlou-Litina DI; Eleftheriou PT; Filimonov DA; Poroikov VV; Alam I; Saxena AK
J Med Chem; 2008 Mar; 51(6):1601-9. PubMed ID: 18311898
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis.
Lee JH; Kim GH
J Food Sci; 2010 Sep; 75(7):H212-7. PubMed ID: 21535545
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of maesanin and analogs on arachidonic acid metabolizing enzymes.
Abourashed EA; Muhammad I; Resch M; Bauer R; el-Feraly FS; Hufford CD
Planta Med; 2001 Jun; 67(4):360-1. PubMed ID: 11458456
[TBL] [Abstract][Full Text] [Related]
25. Naturally occurring biflavonoid, ochnaflavone, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells.
Son MJ; Moon TC; Lee EK; Son KH; Kim HP; Kang SS; Son JK; Lee SH; Chang HW
Arch Pharm Res; 2006 Apr; 29(4):282-6. PubMed ID: 16681032
[TBL] [Abstract][Full Text] [Related]
26. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?
Fiorucci S; Meli R; Bucci M; Cirino G
Biochem Pharmacol; 2001 Dec; 62(11):1433-8. PubMed ID: 11728379
[TBL] [Abstract][Full Text] [Related]
27. Modulation of lipoxygenase activity by bacterial hopanoids.
Moreau RA; Agnew J; Hicks KB; Powell MJ
J Nat Prod; 1997 Apr; 60(4):397-8. PubMed ID: 9134748
[TBL] [Abstract][Full Text] [Related]
28. Avarol restores the altered prostaglandin and leukotriene metabolism in monocytes infected with human immunodeficiency virus type 1.
Schröder HC; Bégin ME; Klöcking R; Matthes E; Sarma AS; Gasić M; Müller WE
Virus Res; 1991 Nov; 21(3):213-23. PubMed ID: 1662847
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anti-inflammatory activity of chalcone derivatives.
Herencia F; Ferrándiz ML; Ubeda A; Domínguez JN; Charris JE; Lobo GM; Alcaraz MJ
Bioorg Med Chem Lett; 1998 May; 8(10):1169-74. PubMed ID: 9871729
[TBL] [Abstract][Full Text] [Related]
30. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids.
Moroney MA; Alcaraz MJ; Forder RA; Carey F; Hoult JR
J Pharm Pharmacol; 1988 Nov; 40(11):787-92. PubMed ID: 2907559
[TBL] [Abstract][Full Text] [Related]
31. Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines.
Mandal P; Kundu BK; Vyas K; Sabu V; Helen A; Dhankhar SS; Nagaraja CM; Bhattacherjee D; Bhabak KP; Mukhopadhyay S
Dalton Trans; 2018 Jan; 47(2):517-527. PubMed ID: 29235601
[TBL] [Abstract][Full Text] [Related]
32. The sensitivity of bovine corneal epithelial lyso-PAF acetyltransferase to cyclooxygenase and lipoxygenase inhibitors is independent of arachidonate metabolites.
Hurst JS; Bazan HE
J Ocul Pharmacol Ther; 1997 Oct; 13(5):415-26. PubMed ID: 9326723
[TBL] [Abstract][Full Text] [Related]
33. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.
Futaki N; Takahashi S; Yokoyama M; Arai I; Higuchi S; Otomo S
Prostaglandins; 1994 Jan; 47(1):55-9. PubMed ID: 8140262
[TBL] [Abstract][Full Text] [Related]
34. Outstanding Anti-inflammatory Potential of Selected Asteraceae Species through the Potent Dual Inhibition of Cyclooxygenase-1 and 5-Lipoxygenase.
Chagas-Paula DA; Oliveira TB; Faleiro DP; Oliveira RB; Costa FB
Planta Med; 2015 Sep; 81(14):1296-307. PubMed ID: 26227502
[TBL] [Abstract][Full Text] [Related]
35. Effects of tebufelone (NE-11740), a new anti-inflammatory drug, on arachidonic acid metabolism.
Weisman SM; Doyle MJ; Wehmeyer KR; Hynd BA; Eichhold TH; Clear RM; Coggeshall CW; Kuhlenbeck DL
Agents Actions; 1994 May; 41(3-4):156-63. PubMed ID: 7942323
[TBL] [Abstract][Full Text] [Related]
36. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
37. Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.
Celotti F; Laufer S
Pharmacol Res; 2001 May; 43(5):429-36. PubMed ID: 11394934
[TBL] [Abstract][Full Text] [Related]
38. Effect of nimesulide action time dependence on selectivity towards prostaglandin G/H synthase/cyclooxygenase activity.
Vago T; Bevilacqua M; Norbiato G
Arzneimittelforschung; 1995 Oct; 45(10):1096-8. PubMed ID: 8595067
[TBL] [Abstract][Full Text] [Related]
39. Flavonoids and a sesquiterpene lactone from Tanacetum microphyllum inhibit anti-inflammatory mediators in LPS-stimulated mouse peritoneal macrophages.
Abad MJ; Bermejo P; Alvarez M; Guerra JA; Silván AM; Villar AM
Planta Med; 2004 Jan; 70(1):34-8. PubMed ID: 14765290
[TBL] [Abstract][Full Text] [Related]
40. In vitro effects of E3040, a dual inhibitor of 5-lipoxygenase and thromboxane A(2) synthetase, on eicosanoid production.
Oketani K; Nagakura N; Harada K; Inoue T
Eur J Pharmacol; 2001 Jun; 422(1-3):209-16. PubMed ID: 11430933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
